PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsfemale infertility
MeSH D007247 - female infertility
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007246:Infertility
22 Companies
7 Drugs
$
Success rate
D005831:Female genital diseases
2 Companies
2 Drugs
$
Success rate
D007247: 
Female infertility
33 Companies
13 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaEstradiol, Norgestimate Prefest  1999-10-22   
Progesterone Progesterone  2012-02-29   
Novast LaboratoriesEthinyl estradiol, Norgestimate Mono-linyah  2012-05-23   
Ethinyl estradiol, Norgestimate Tri-linyah  2012-05-30   
Ethinyl estradiol, Norgestimate Tri-lo-linyah  2022-09-02   
Glenmark PharmaceuticalsEthinyl estradiol, Norgestimate Norgestimate Ethinyl Estradiol  2011-06-17   
MylanEthinyl estradiol, Norgestimate Norgestimate Ethinyl Estradiol  2016-01-27   
XiromedEthinyl estradiol, Norgestimate Norgestimate Ethinyl Estradiol  2016-01-27   
Ethinyl estradiol, Norgestimate Estarylla  2013-01-30   
Progesterone Progesterone  2017-10-20   
Ethinyl estradiol, Norgestimate Tri-estarylla  2013-01-30   
Ethinyl estradiol, Norgestimate Tri-lo-estarylla  2015-06-29   
Johnson & JohnsonEthinyl estradiol, Norgestimate Ortho Cyclen  1989-12-29   
Ethinyl estradiol, Norgestimate Ortho Tri-cyclen  1992-07-03   
Ethinyl estradiol, Norgestimate Ortho Tri-cyclen Lo  2002-08-22   
Lupin ResearchEthinyl estradiol, Norgestimate Norgestimate Ethinyl Estradiol  2012-06-25   
OrganonGanirelix Orgalutran  2000-05-16 $125 M Q3/22-Q2/23 
SanofiClomiphene Clomid  1982-01-01   
Merck & CoFollitropin alfa Gonal-f  1995-10-20   
Lutropin alfa Luveris  2000-11-29   
Choriogonadotropin alfa Ovitrelle  2001-02-02   
Lutropin alfa, Follitropin alfa Pergoveris  2007-06-25   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
76%
16/21
Phase 2
38%
8/21
Phase 3
65%
30/46
Approved: 12Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Estradiol,
Estradiol benzoate,
Estradiol valerate,
Norgestimate,
Progesterone
Mylan
Ethinyl estradiol,
Norgestimate
Johnson & Johnson
Ethinyl estradiol,
Norgestimate
Organon
Ganirelix,
Ganirelix acetate,
Follitropin
Merck & Co
Choriogonadotropin alfa,
Lutropin alfa,
Follitropin alfa,
Benzocaine,
Follitropin
Allergan
Ethinyl estradiol,
Norgestimate,
Progesterone
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use